{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:16:58Z","timestamp":1790140618937,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1186\/s12889-019-6784-3","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T09:23:19Z","timestamp":1557480199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination"],"prefix":"10.1186","volume":"19","author":[{"given":"Liesl M.","family":"Hagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Kasradze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Salyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amiran","family":"Gamkrelidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Alkhazashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gvantsa","family":"Chanturia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazibrola","family":"Chitadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roena","family":"Sukhiashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Shakhnazarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Blanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgi","family":"Kuchukhidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davit","family":"Baliashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paata","family":"Imnadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Drobeniuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Averhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"6784_CR1","unstructured":"World Health Organization. Global Hepatitis Report 2017 [Available from: \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/255016\/1\/9789241565455-eng.pdf?ua=1\n                    \n                  . Accessed 19 Jul 2017.]"},{"issue":"17","key":"6784_CR2","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","volume":"13","author":"MJ Alter","year":"2007","unstructured":"Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436\u201341.","journal-title":"World J Gastroenterol"},{"key":"6784_CR3","unstructured":"Institute of Medicine. Hepatitis and liver cancer: a National Strategy for prevention and control of hepatitis B and C. Washington, DC; 2010."},{"issue":"1","key":"6784_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Lauer","year":"2001","unstructured":"Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41\u201352.","journal-title":"N Engl J Med"},{"key":"6784_CR5","doi-asserted-by":"crossref","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095\u2013128.","DOI":"10.1016\/S0140-6736(12)61728-0"},{"key":"6784_CR6","unstructured":"World Health Organization. Hepatitis C Fact Sheet N 164 2015 [Available from: \n                    http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/\n                    \n                  . Accessed 9 Feb 2016.]"},{"issue":"4","key":"6784_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","volume":"45","author":"JF Perz","year":"2006","unstructured":"Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529\u201338.","journal-title":"J Hepatol"},{"key":"6784_CR8","unstructured":"National Statistics Office of Georgia. Key Indicators 2015 [Available from: \n                    http:\/\/www.geostat.ge\/index.php?action=0&lang=eng\n                    \n                  . Accessed 12 Feb 2016.]"},{"issue":"2","key":"6784_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11524-006-9032-y","volume":"83","author":"K Stvilia","year":"2006","unstructured":"Stvilia K, Tsertsvadze T, Sharvadze L, Aladashvili M, del Rio C, Kuniholm MH, et al. Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T'bilisi, republic of Georgia. J Urban Health. 2006;83(2):289\u201398.","journal-title":"J Urban Health"},{"issue":"28","key":"6784_CR10","doi-asserted-by":"publisher","first-page":"753","DOI":"10.15585\/mmwr.mm6428a2","volume":"64","author":"K Mitruka","year":"2015","unstructured":"Mitruka K, Tsertsvadze T, Butsashvili M, Gamkrelidze A, Sabelashvili P, Adamia E, et al. Launch of a Nationwide hepatitis C elimination program--Georgia, April 2015. MMWR Morb Mortal Wkly Rep. 2015;64(28):753\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"247","key":"6784_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/01621459.1949.10483314","volume":"44","author":"L Kish","year":"1949","unstructured":"Kish L. A procedure for objective respondent selection within the household. J Am Stat Assoc. 1949;44(247):380\u20137.","journal-title":"J Am Stat Assoc"},{"key":"6784_CR12","unstructured":"National Statistics Office of Georgia. Household Income 2015 [Available from: \n                    http:\/\/www.geostat.ge\/index.php?action=page&p_id=182&lang=eng\n                    \n                  . Accessed 5 Jul 2016.]"},{"key":"6784_CR13","unstructured":"European Union HCV Policy Summit. HCV elimination manifesto: The beginning of the end Brussels, Belgium2016 [Available from: \n                    http:\/\/www.hcvbrusselssummit.eu\/elimination-manifesto\n                    \n                  . Accessed 16 Sep 2016.]"},{"key":"6784_CR14","unstructured":"Hepatitis Australia. Australia leads the world in curing hepatitis C as record numbers treated 2016 [Available from: \n                    http:\/\/www.hepatitisaustralia.com\/newsarticles\/australia-leads-the-world-in-curing-hepatitis-c-as-record-numbers-treated\/28\/7\/2016\n                    \n                  . Accessed 16 Sep 2016.]"},{"key":"6784_CR15","unstructured":"Oklahoma State Department of Health. Setting a path towards HCV elimination in the Cherokee Nation: government, academia, and pharma collaboration 2016 [Available from: \n                    http:\/\/www.hhs.gov\/hepatitis\/blog\/2016\/04\/08\/setting-path-towards-hcv-elimination-cherokee-nation-government-academia-and-pharma-collaboration\n                    \n                  . Accessed 16 Sep 2016.]"},{"key":"6784_CR16","unstructured":"World Health Organization. Combating hepatitis B and C to reach elimination by 2030 2016 [Available from: \n                    http:\/\/www.who.int\/hepatitis\/publications\/hep-elimination-by-2030-brief\/en\/\n                    \n                  . Accessed 16\/09\/2016.]"},{"key":"6784_CR17","volume-title":"TRAP HEP C - treatment as prevention for hepatitis C in Iceland: a nationwide elimination program using direct acting antiviral agents","author":"M Gottfredsson","year":"2017","unstructured":"Gottfredsson M, Bergmann O, Tyrfingsson T, Runarsdottir V, Bjornsson E, Johannsson B, et al. TRAP HEP C - treatment as prevention for hepatitis C in Iceland: a nationwide elimination program using direct acting antiviral agents. Stockholm: HIV & Hepatitis Nordic Conference; 2017."},{"issue":"41","key":"6784_CR18","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.15585\/mmwr.mm6541a2","volume":"65","author":"L Gvinjilia","year":"2016","unstructured":"Gvinjilia L, Nasrullah M, Sergeenko D, Tsertsvadze T, Kamkamidze G, Butsashvili M, et al. National progress toward hepatitis C elimination - Georgia, 2015-2016. MMWR Morb Mortal Wkly Rep. 2016;65(41):1132\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"6784_CR19","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/hep.27978","volume":"62","author":"BR Edlin","year":"2015","unstructured":"Edlin BR, Eckhardt BJ, Shu MA, Holmberg SD, Swan T. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology. 2015;62(5):1353\u201363.","journal-title":"Hepatology."},{"key":"6784_CR20","doi-asserted-by":"crossref","unstructured":"Harris A, Biddle J, Chokoshvili O, Turashvili K, Japaridze M, Burjanadze I, et al. A public health approach to hepatitis C testing, care and treatment in the country of Georgia's corrections system. BMC Public Health. 2019;19(S3).","DOI":"10.1186\/s12889-019-6783-4"},{"issue":"4","key":"6784_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/pubmed\/fdg088","volume":"25","author":"LC Sherriff","year":"2003","unstructured":"Sherriff LC, Mayon-White RT. A survey of hepatitis C prevalence amongst the homeless community of Oxford. J Public Health Med. 2003;25(4):358\u201361.","journal-title":"J Public Health Med"},{"issue":"1","key":"6784_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/eurpub\/ckm072","volume":"18","author":"V Volf","year":"2008","unstructured":"Volf V, Marx D, Pliskova L, Sumegh L, Celko A. A survey of hepatitis B and C prevalence amongst the homeless community of Prague. Eur J Pub Health. 2008;18(1):44\u20137.","journal-title":"Eur J Pub Health"},{"issue":"10","key":"6784_CR23","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1080\/10826080802108293","volume":"43","author":"MH Kuniholm","year":"2008","unstructured":"Kuniholm MH, Aladashvili M, Del Rio C, Stvilia K, Gabelia N, Chitale RA, et al. Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia. Subst Use Misuse. 2008;43(10):1424\u201337.","journal-title":"Subst Use Misuse"},{"issue":"29","key":"6784_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.15585\/mmwr.mm6629a2","volume":"66","author":"M Nasrullah","year":"2017","unstructured":"Nasrullah M, Sergeenko D, Gvinjilia L, Gamkrelidze A, Tsertsvadze T, Butsashvili M, et al. The role of screening and treatment in National Progress toward Hepatitis C Elimination - Georgia, 2015-2016. MMWR Morb Mortal Wkly Rep. 2017;66(29):773\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6784_CR25","volume-title":"Characteristics of high-risk behaviors and knowledge of STI\/HIV and prevalence of HIV, syphilis and hepatitis among injecting drug users in Tbilisi, Batumi, and Kutaisi, Georgia 2002\u20132006","author":"USAID Behavioral Surveillance Survey Repo","year":"2006","unstructured":"Behavioral Surveillance Survey Report USAID. Characteristics of high-risk behaviors and knowledge of STI\/HIV and prevalence of HIV, syphilis and hepatitis among injecting drug users in Tbilisi, Batumi, and Kutaisi, Georgia 2002\u20132006; 2006."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-6784-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T23:04:55Z","timestamp":1588979095000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-6784-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":25,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["6784"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-6784-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"10 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval\u00a0was obtained from the\u00a0Georgia National Center for Disease Control and Public Health Institutional Review Board. This survey was determined to be a routine public health activity for public health surveillance by CDC\u2019s Human Subjects Research Office and therefore judged to not involve human subjects research. All participants signed a consent form in their preferred language; the form explained the purpose of the survey, provided contact information for the Principal Investigator, informed participants that they could decline to answer any questions they chose, and assured them that their participation would not influence health care services they receive through the Georgian government.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"480"}}